News Quantified

DVAX – dynavax technologies corporation (US:NASDAQ)

Stock Stats

News Stats

Order Stats

News

CDC vaccine panel set to debate hepatitis b shots, childhood immunizations [Seeking Alpha]

Dynavax to Participate at the 8th Annual Evercore Healthcare Conference [Yahoo! Finance]

Dynavax to Participate at the 8th Annual Evercore Healthcare Conference

Vaxart Inc (VXRT) Q3 2025 Earnings Call Highlights: Strategic Partnership and Revenue Surge ... [Yahoo! Finance]

Vaxart extends cash runway into Q2 2027 with Dynavax partnership and targets 2026 data readouts [Seeking Alpha]

7.7%

BEAT

-6.6%

BEAT

-11.0%

MISS

0.0%

BEAT

Form 10-Q DYNAVAX TECHNOLOGIES For: Sep 30

Form 8-K DYNAVAX TECHNOLOGIES For: Nov 05

Form 8-K DYNAVAX TECHNOLOGIES For: Oct 15

Top News Gainers

8/7 Form 424B5 DYNAVAX TECHNOLOGIES 21.2%

5/8 Q1/2019 3/31/2019 EPS -0.620 ZacksConsensus -0.670 ActVsEst 0.050 - Beat 17.8%

3/13 Earnings Update: Dynavax Technologies Corporation Just Reported And Analysts Are Trimming Their Forecasts [Yahoo! Finance News] 15.9%

3/16 Form 4 DYNAVAX TECHNOLOGIES For: Mar 13 Filed by: Johnson David Louis 14.0%

8/8 Form 424B5 DYNAVAX TECHNOLOGIES 11.6%

4/28 Dynavax Reports Interim Analysis of Ongoing Clinical Trial Evaluating HEPLISAV-B in Patients Undergoing Hemodialysis 7.8%

8/16 Dynavax Technologies Co. (NASDAQ: DVAX) was upgraded by analysts at Zacks Investment Research from a "hold" rating to a "buy" rating. They now have a $4.50 price target on the stock. 7.7%

8/13 Form S-8 DYNAVAX TECHNOLOGIES 6.8%

3/19 Dynavax Technologies Co. (NASDAQ: DVAX) was upgraded by analysts at BidaskClub from a "strong sell" rating to a "sell" rating. 6.8%

8/12 Form 4 DYNAVAX TECHNOLOGIES For: Aug 12 Filed by: Novack David F 6.4%

Top News Decliners

3/11 Q4/2019 12/31/2019 EPS -0.440 ZacksConsensus -0.330 ActVsEst (0.110) - Miss -22.9%

3/24 Dynavax and Clover Biopharmaceuticals Announce Research Collaboration to Evaluate Coronavirus (COVID-19) Vaccine Candidate with CpG 1018 Adjuvant -19.1%

3/2 Dynavax Announces Collaboration with the University of Queensland and the Coalition for Epidemic Preparedness (CEPI) Focused on the Development of a Coronavirus (COVID-19) Vaccine -18.2%

5/24 Dynavax Technologies Co. (NASDAQ: DVAX) had its price target lowered by analysts at Royal Bank of Canada to $13.00. They now have an "outperform" rating on the stock. -14.0%

7/4 Why Dynavax Technologies' Stock Tanked in June [The Motley Fool] -13.4%

5/11 Dynavax Technologies Co. (NASDAQ: DVAX) had its "outperform" rating re-affirmed by analysts at William Blair. -11.6%

3/12 Form 4 DYNAVAX TECHNOLOGIES For: Mar 11 Filed by: Hack Andrew A. F. -11.1%

7/10 Dynavax Technologies Co. (NASDAQ: DVAX) was upgraded by analysts at Cantor Fitzgerald from a "neutral" rating to an "overweight" rating. -11.1%

4/2 Dynavax Provides Business Update on COVID-19 Pandemic Impact -9.7%

6/4 Form 4 DYNAVAX TECHNOLOGIES For: Jun 02 Filed by: COFFMAN ROBERT -8.8%

Live Event: How Top Hedge Funds Use News To Make Money From The Stock Market & How Ordinary People Are Copying Their Strategies

If you could use the news to make money from the stock market, would you? Join us on our live online event where you’ll discover this simple scientific method that has allowed ordinary people get a huge return from the stock market without excessive risk.

Click Here To Register For The Live Online Workshop

In short, News Quantified specializes in matching financial news with market data. We've analyzed 10s of millions of news events and know exactly which ones have an outsized impact on stock prices. So every single time a news item is released we know exactly what the average effect will be on a particular stock.

Latest Posts

Trading the Google Earnings Announcement: A Strategic Preview

Earnings Week Wrap-up and Takeaways

Earnings Season: Q3 Review, Q4 Kickoff – Morgan Stanley, Bank of America, Goldman Sachs, Netflix

Guerrilla Learning Opportunity: Wealth365 Conference Featuring News Quantified Founder and Much More

The Smart Way to Ten Minutes Per Day